November 18, 2019
By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. An annual global survey conducted by the American College of Sports Medicine recently predicted that […]
December 5, 2019
Most of the top research and development executives across the biopharma industry are earning around $7M a year. One would think that this list would correspond […]
December 5, 2019
Facing thousands of state and local civil lawsuits, opioid makers are scrambling to sign a deal to escape the multibillion-dollar consequences. However, they may soon have […]
December 5, 2019
To confront rising insulin prices this year, Eli Lilly introduced a generic version of its Humalog priced at half the cost. Now the company is investing […]
December 5, 2019
Fujifilm is continuing its aggressive expansion efforts with a major investment in its U.S. gene therapy operation by making a $120M addition to its Texas facilities. […]
December 5, 2019
Aiming to become the first fully VR-based hospital in the world, Israel’s Sheba Medical Center is incorporating virtual reality throughout each of its hospital departments, including […]
December 6, 2019
A NEW POINT OF VIEW LEADS TO A POTENTIAL NEW TREATMENT When venture capitalist Martin Lehr decided he wanted a better understanding of the biopharma companies […]
December 13, 2019
From AstraZeneca to Zolgensma, these are the companies, executives and drugs that shaped the biopharma industry this year. Check out who won below: Biotech of […]
December 20, 2019
Clinical trials are the most important and expensive step of getting a new drug approved, and it’s no secret that the chances of success are slim. […]